Nineteen novel drugs have been selected for inclusion in the first iteration of China's Commercial Health Insurance Innovative Drug Catalogue, portending potential access benefits as the program ga | ...
Negotiations are expected to continue in future cycles as part of President Donald Trump's "aggressive push for lower prices.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback